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Abstract: Cell communication via exosomes is capable of influencing cell fate in stress situations
such as exposure to ionizing radiation. In vitro and in vivo studies have shown that exosomes might
play a role in out-of-target radiation effects by carrying molecular signaling mediators of radiation
damage, as well as opposite protective functions resulting in resistance to radiotherapy. However,
a global understanding of exosomes and their radiation-induced regulation, especially within the
context of an intact mammalian organism, has been lacking. In this in vivo study, we demonstrate
that, compared to sham-irradiated (SI) mice, a distinct pattern of proteins and miRNAs is found
packaged into circulating plasma exosomes after whole-body and partial-body irradiation (WBI and
PBI) with 2 Gy X-rays. A high number of deregulated proteins (59% of WBI and 67% of PBI) was
found in the exosomes of irradiated mice. In total, 57 and 13 miRNAs were deregulated in WBI
and PBI groups, respectively, suggesting that the miRNA cargo is influenced by the tissue volume
exposed to radiation. In addition, five miRNAs (miR-99b-3p, miR-200a-3p, miR-200a, miR-182-5p,
miR-182) were commonly overexpressed in the exosomes from the WBI and PBI groups. In this
study, particular emphasis was also given to the determination of the in vivo effect of exosome
transfer by intracranial injection in the highly radiosensitive neonatal cerebellum at postnatal day 3.
In accordance with a major overall anti-apoptotic function of the commonly deregulated miRNAs,
here, we report that exosomes from the plasma of irradiated mice, especially in the case of WBI,
prevent radiation-induced apoptosis, thus holding promise for exosome-based future therapeutic
applications against radiation injury.
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1. Introduction
Evidence accumulated over the past two decades has indicated that the effects of
ionizing radiation are not restricted to irradiated cells but also to non-irradiated bystander
or even distant cells manifesting various biological effects. These phenomena have been
termed “non-(DNA)-targeted” [1] and include radiation-induced bystander effects [2],
genomic instability [3,4], adaptive response [5], low-dose hyper-radiosensitivity [6], delayed
reproductive death and induction of genes by radiation [7]. All of these biological effects
indicate the involvement of molecules not directly targeted by radiation.
Exosomes, a subtype of extracellular vesicles (EV), are released from cells into the
extracellular space and are capable of transporting cargo (e.g., DNA, RNA, and proteins)
between cells as a form of intercellular communication [8–10]. MiRNAs are the most
abundant cargo in the exosome [11]. They are endogenous non-coding RNA molecules
approximately 19–22 nt-long, and important regulators of the protein expression. Proteins,
RNA, and other molecules are not randomly loaded into EVs. On the contrary, specialized
mechanisms act to ensure a specific cargo, which will define the outcome of communication
between the EV producer and the recipient cell. Although the molecular mechanisms
that regulate the loading of proteins into EVs have been studied for years, the sorting
mechanism of the cargo has been elusive until recently.
EVs including exosomes are secreted by a wide range of cells including immune,
neuronal, and cancer cells [12–16]. They are released into the extracellular space and can be
found in body fluids such as blood. Of note, the molecular content of exosomes and the
biological function that they perform is influenced by the cell type of origin [17]. Circulating
blood-derived EVs, secreted from multiple types of cells, offer advantages compared to
single cell type-derived EVs in that they may more faithfully recapitulate the complexity of
their functions in physiological and pathological conditions.
Recent reports have indicated that the multiple roles of EVs are largely dependent
on the physiological state of the donor cell [18–21]. Environmental challenges, such as
activation or stress conditions, are known to modulate the composition, biogenesis, and
secretion of EVs. Stress situations such as hypoxia, starvation, or oxidative stress can alter
the exosome content, and thus the message they carry [22].
Exposure to ionizing radiation is among the well-established extracellular factors
known to affect EV-based cellular communications, although the mechanisms of this
phenomenon are still far from being understood. Previous studies have shown that EV
secretion is increased with ionizing radiation exposure in a time- and dose-dependent
manner [23–25]. While the therapeutic capabilities of exosomes against radiation damage
are being studied [26–31], growing evidence supports exosomes as key players in radiationinduced bystander effects [32–34]. In particular, exosome-mediated miRNA transfer has
been shown to play important roles in bystander effects, and exosomes isolated from
irradiated conditioned medium have been shown to induce these effects [35]. Nevertheless,
there is a big gap in understanding how radiation-induced changes in the composition of
exosomes translate into their functional importance.
In this study, to delineate the radiation-induced changes in miRNAs and protein
cargo, we established the microRNA and proteome profiles of plasma exosomes collected
from mice that had been sham- (SI), whole-body- (WBI), or partial-body irradiated (PBI)
in the lower third of the body with a clinically relevant dose of 2 Gy X-rays 24 h earlier.
Spatial variations in dose delivery are relevant for humans as radiation exposure scenario
including different PBI patterns are the norm in diagnostic radiology, radiation therapy,
and occupational exposures and may have significant implications for human health at
low- and intermediate-radiation doses [36–39].
Furthermore, to understand how radiation-induced changes in the miRNA and protein exosomes cargo influence the stress response of distant cells by propagating either
damaging or protective signals, we applied an in vivo functional assay interrogating the
cerebellum of neonatal mice at postnatal day 3 (P3), highly susceptible to radiation injury.
In fact, P3 mouse cerebellum is comparable to the human gestational period of 22–23 weeks,
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2. Results
2. Results
2.1. MicroRNA Profile of Circulating Plasma Exosomes from 2 Gy WBI and PBI Mice
2.1. MicroRNA Profile of Circulating Plasma Exosomes from 2 Gy WBI and PBI Mice
Increasing data demonstrate that miRNAs can influence the way that cells respond
Increasing data demonstrate that miRNAs can influence the way that cells respond
to ionizing radiation, making them more radioresistant or radiosensitive through specific
to ionizing radiation, making them more radioresistant or radiosensitive through specific
pathways. To investigate radiation effects on miRNAs cargo, we performed NGS-based
pathways. To investigate radiation effects on miRNAs cargo, we performed NGS-based
miRNome analysis of plasma exosomes from WBI, PBI, and SI mice at 24 h
miRNome analysis of plasma exosomes from WBI, PBI, and SI mice at 24 h post-irradiation.
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The quality check of the samples showed high scores in nearly all the reads (Figure 2A),
reads (Figure 2A), as their number was substantially unchanged after quality assessment.
as their number was substantially unchanged after quality assessment. The pie charts in
The pie charts in Figure 2B, illustrating an overview of the distribution of small RNAs in
Figure 2B, illustrating an overview of the distribution of small RNAs in plasma exosomes,
plasma exosomes, indicated an increase in miRNA content in exosomes from WBI and
indicated an increase in miRNA content in exosomes from WBI and PBI compared to
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Figure 2. (A) Numbers of reads pre- and post-quality filtering and (B) characterization of mouse
Figure 2. (A) Numbers of reads pre- and post-quality filtering and (B) characterization of mouse
plasma exosomal small non-coding RNA content. The dataset for each treatment group—SI, WBI,
plasma exosomal small non-coding RNA content. The dataset for each treatment group—SI, WBI,
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fraction of miRNAs is marked by an arrow.
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Next, we investigated the changes in exosomal miRNA content after WBI and PBI
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Figure 3. Volcano plots analysis. Fold-change and p-values of all differentially expressed miRNAs
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miRNAsSigin the
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2.2. Pathway Analysis of Differentially Regulated miRNAs
Next, we looked for biological functions associated with miRNAs that were signifi2.2.
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2.0 Gy identified 1001 proteins in total, of which 735 were identified by two unique peptides
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Thesupervised
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S3).
separation between SI controls and irradiated samples but did not discriminate between
the PBI and WBI samples (Figure 5A).
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Figure 5. Proteomics analysis of the plasma exosomes 24 h after partial-body irradiation (2 Gy PBI)
or whole-body irradiation (2 Gy WBI) compared to the sham-irradiated (SI) controls. (A) Supervised
Figure 5. Proteomics analysis of the plasma exosomes 24 h after partial-body irradiation (2 Gy PBI)
heat
map showing the separation of PBI and WBI samples from controls based on the significantly
or whole-body irradiation (2 Gy WBI) compared to the sham-irradiated (SI) controls. (A) Superdifferentially
expressed
proteins
in each
condition
> 0.05,from
foldcontrols
changebased
> 1.30
0.77, protein
vised heat map
showing the
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of PBI
and WBI(q
samples
on or
the<significantly differentially
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proteins
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> 1.30 between
or < 0.77, the WBI
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Thethe
heatgreen
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and
PBI samples.
Thewith
red bars
indicate
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tween the WBI and PBI samples. The red bars indicate upregulation and the green bars downregdiagram showing the number of total and shared significantly differentially regulated proteins using
ulation. (B) Venn diagram showing the number of total and shared significantly differentially regPBI
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circle)using
and WBI
(redcircle)
circle)and
compared
the compared
SI controls.
(C)SIProtein
interaction
ulated
proteins
PBI (blue
WBI (red to
circle)
to the
controls.
(C) Proteinanalysis
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all significantly
differentially
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are shown:
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balls),in blood
mitochondrial
(blue
balls), ribosomal
proteins
(yellow
balls), and
proteins
involved
and proteins involved in blood coagulation (red balls). The analysis was performed using the
coagulation (red balls). The analysis was performed using the STRING database [42].
STRING database [42].

This was also seen in the differentially regulated proteins. When compared to the
This was also seen in the differentially regulated proteins. When compared to the
plasma
69 proteins
proteinsusing
usingPBI
PBIand
andWBI,
WBI,respectively,
respectively, were
plasmaexosomes
exosomesfrom
fromSI
SIanimals,
animals, 75
75 and
and 69
differentially
regulated
(Tables
S4
and
S5).
Of
these,
more
than
half,
namely
5151
proteins,
were differentially regulated (Tables S4 and S5). Of these, more than half, namely
were
deregulated
at
both
radiation
conditions
(Figure
5B),
and
the
direction
of
deregulation
proteins, were deregulated at both radiation conditions (Figure 5B), and the direction of
was
always similar
(Tables
S4 and
S5). S4 and S5).
deregulation
was always
similar
(Tables
The
Theprotein–protein
protein–protein interaction
interaction analysis
analysis of
ofthe
thederegulated
deregulatedproteins
proteinsusing
usingPBI
PBIshowed
showed
three
protein
clusters:
mitochondrial
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and
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(Figure
Similar
smallerclusters
clusters were
were also
coagulation
system
(Figure
5C). 5C).
Similar
butbut
smaller
alsofound
foundusing
using WBI
WBI
(data
not
shown).
(data not shown).
The ribosomal and coagulation-associated acute phase proteins were downregulated,
whereas most of the mitochondrial proteins were upregulated in the PBI samples compared
to SI controls (Table 1). Additionally, cell-adhesion proteins CD34 and platelet endothelial
cell adhesion molecule (Pecam1), as well as serum amyloid A-1 protein (Saa1) were upregulated in both radiation conditions (PBI and WBI) (Table 1, Tables S4 and S5). Interestingly,
a high number of proteins (67% for PBI and 59% for WBI) were only present in the plasma
exosomes from irradiated animals but not in the SI samples (Table 1), indicating that the
cargo is highly influenced by irradiation, be it partial- or whole-body exposure.
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Table 1. Significantly differentially regulated proteins in mouse blood exosomes of PBI at 2 Gy.
Accession
Q9D0M3

Description
Cytochrome c1, heme protein, mitochondrial

Gene Symbol

Abundance Ratio
(2 Gy, PBI)/0 Gy)

Cyc1

0.010

O54990

Prominin-1

Prom1

0.010

Q8JZM8

Mucin-4

Muc4

0.010

Q62168

Keratin, type I cuticular Ha2

Krt32

0.010

Q497I4

Keratin, type I cuticular Ha5

Krt35

0.010

O70456

14-3-3 protein sigma

Sfn

0.010

P97350

Plakophilin-1

Pkp1

0.010

Q8BZ98

Dynamin-3

Dnm3

0.010

P70315

Wiskott–Aldrich syndrome protein homolog

Was

0.010

Q923U0

TOM1-like protein 1

Tom1l1

0.010

P47963

60S ribosomal protein L13

Rpl13

0.010

P12970

60S ribosomal protein L7a

Rpl7a

0.010

P62281

40S ribosomal protein S11

Rps11

0.010

O09167

60S ribosomal protein L21

Rpl21

0.010

P62717

60S ribosomal protein L18a

Rpl18a

0.010

Q8VCM7

Fibrinogen gamma chain

Fgg

0.031

Q8K0E8

Fibrinogen beta chain

Fgb

0.038

E9PV24

Fibrinogen alpha chain

Fga

0.040

Q9D3D9

ATP synthase subunit delta, mitochondrial

Atp5d

0.040

Q7TMD7

Desmoglein-4

Dsg4

0.094

Emilin1

0.096

Q99K41

EMILIN-1

P97861

Keratin, type II cuticular Hb6

Krt86

0.106

Q60841

Reelin

Reln

0.139

Q9JHJ0

Tropomodulin-3

Tmod3

0.143

Q3SXB8

Collectin-11

Colec11

0.143

Q8BH61

Coagulation factor XIII A chain

F13a1

0.151

Q8R0Z6

Angiopoietin-related protein 6

Angptl6

0.154

P15864

Histone H1.2

Hist1h1c

0.168

Q9JLY7

Dual specificity protein phosphatase 14

Dusp14

0.180

Q63836

Selenium-binding protein 2

Selenbp2

0.184

Q8CF98

Collectin-10

Colec10

0.184

P62806

Histone H4

Hist1h4j

0.187

Q9D1R9

60S ribosomal protein L34

Rpl34

0.189

P84099

60S ribosomal protein L19

Rpl19

0.201

Q07968

Coagulation factor XIII B chain

F13b

0.204

Q6ZWV3

60S ribosomal protein L10

Rpl10

0.210

P62267

40S ribosomal protein S23

Rps23

0.244

P17710

Hexokinase-1

Hk1

5.598

P19783

Cytochrome c oxidase subunit 4 isoform 1, mitochondrial

Cox4i1

6.534

Q64521

Glycerol-3-phosphate dehydrogenase, mitochondrial

Gpd2

6.570
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Table 1. Cont.
Accession

Description

Gene Symbol

Abundance Ratio
(2 Gy, PBI)/0 Gy)

Cd34

8.780

Q64314

Hematopoietic progenitor cell antigen CD34

Q9Z126

Platelet factor 4

Pf4

14.195

Electron transfer flavoprotein subunit beta

Etfb

100.00

Q9DCW4
Q8K021

Secretory carrier-associated membrane protein 1

Scamp1

100.00

Q4FJU9

Transmembrane protein 40

Tmem40

100.00

P70168

Importin subunit beta-1

Kpnb1

100.00

Q61559

IgG receptor FcRn large subunit p51

Fcgrt

100.00

Q8VEK3

Heterogeneous nuclear ribonucleoprotein U

Hnrnpu

100.00

B2RUP2

Protein unc-13 homolog D

Unc13d

100.00

Q7TQ48

Sarcalumenin

Srl

100.00

P51660

Peroxisomal multifunctional enzyme type 2

Hsd17b4

100.00

P53994

Ras-related protein Rab-2A

Rab2a

100.00

Q91VD9

NADH-ubiquinone oxidoreductase 75 kDa subunit,
mitochondrial

Ndufs1

100.00

Q8BMS1

Trifunctional enzyme subunit alpha, mitochondrial

Hadha

100.00

Gh

100.00

P06880

Somatotropin

Q6Q477

Plasma membrane calcium-transporting ATPase 4

Atp2b4

100.00

O35639

Annexin A3

Anxa3

100.00

Q3TL44

NLR family member X1

Nlrx1

100.00

Q9JIM1

Equilibrative nucleoside transporter 1

Slc29a1

100.00

P35486

Pyruvate dehydrogenase E1 component subunit alpha,
mitochondrial

Pdha1

100.00

O08795

Glucosidase 2 subunit beta

Prkcsh

100.00

Q9ET30

Transmembrane 9 superfamily member 3

Tm9sf3

100.00

Q8K2B3

Succinate dehydrogenase [ubiquinone] flavoprotein
subunit, mitochondrial

Sdha

100.00

P50096

Inosine-5’-monophosphate dehydrogenase 1

Impdh1

100.00

Q99KI0

Aconitate hydratase, mitochondrial

Aco2

100.00

P97429

Annexin A4

Anxa4

100.00

Atp6v0a1

100.00

Pecam1

100.00

Pls1

100.00

Parp4

100.00

Uqcrfs1

100.00

Q9Z1G4

V-type proton ATPase 116 kDa subunit a isoform 1

Q08481

Platelet endothelial cell adhesion molecule

Q3V0K9

Plastin-1

E9PYK3

Protein mono-ADP-ribosyltransferase PARP4

Q9CR68

Cytochrome b-c1 complex subunit Rieske, mitochondrial

P61804

Dolichyl-diphosphooligosaccharide–protein
glycosyltransferase subunit DAD1

Dad1

100.00

P05366

Serum amyloid A-1 protein

Saa1

100.00

Q60864

Stress-induced-phosphoprotein 1

Stip1

100.00

Q8K4F0

CD226 antigen

Cd226

100.00

1

Protein accession number, description, gene symbol, and abundance ratio (fold change) are shown. The
deregulated proteins shared between PBI and WBI are shown in bold. Abundance ratios of 100.00 indicate that
the protein is only found in the irradiated sample.
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2.4. In Vivo Functional Testing of Plasma-Derived Exosomes on Neonatal Mouse Cerebellum
To enhance our understanding of the role of exosomes in the communication between
irradiated and non-irradiated tissues, we evaluated their protective or damaging potential
in vivo (Figure 6A). To this aim, we intracranially injected exosomes derived from SI (0 Gy),
PBI (2 Gy) or WBI (2 Gy) plasma in the cerebellum of recipient unirradiated neonatal mice
(Figure 6B,C). All brain samples were collected at 6 h post-treatment and evaluated for
apoptotic response by immunoblotting, using a cleaved-caspase-3 antibody (Figure 6C).
We first analyzed the apoptotic level in untreated sham-injected (PBS) P3 cerebellum
and compared with that of P3 cerebella injected with plasma exosomes isolated from SI
(0 Gy), PBI (2 Gy), and WBI (2 Gy) at 24 h (Figure 6D,F). We detected a nearly significant
decrease in the apoptotic level of 42.5% (0.4188 vs. 0.7286, p = 0.059) after the injection
of exosomes from SI (0 Gy). Statistically significant decreases of 72.5% (0.2004 vs. 0.7286,
p = 0.0199) and 75.8% (0.1764 vs. 0.7286, p = 0.0012) were observed after the injection of
plasma exosomes from PBI and WBI mice. Additionally, we investigated the influence of
plasma exosomes isolated at an earlier time point of 1 h post-irradiation (Figure 6E,G). A
non-significant decrease in the apoptotic level of 26.5% (0.2004 vs. 0.6927, p = 0.079) and
of 18.8% (0.5624 vs. 0.6927, p = 0.21) was detected after the injection of exosomes from SI
(0 Gy) and PBI (2Gy), respectively. Interestingly, a statistically significant decrease of 59.5%
(0.2803 vs. 0.6927, p = 0.0097) of the cleaved caspase-3 level was observed after the injection
of exosomes from WBI (2 Gy), suggesting that plasma exosomes10originating
from irradiated
Int. J. Mol. Sci. 2022, 23, x FOR PEER REVIEW
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mice from very early on contain signals preventing cell death (Figure 6E,G).
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with a Hamilton microsyringe. (C) Assessment of injection site after microscopic morphological
examination. (D,E) Lane 1: size marker; lane 2: sham-injected cerebellum (PBS); lane 3: cerebellum
injected with 0 Gy-plasma-derived exosomes (EXO 0 Gy); lane 4: cerebellum injected with 2 GyInt. J. Mol. Sci. 2022, 23, x FOR PEER REVIEW
11 of 2
PBI-plasma-derived exosomes (EXO PBI); lane5: cerebellum injected with 2 Gy-WBI-plasma-derived
exosomes (EXO WBI). Band intensities of cleaved-caspase-3 were sampled three times and normalized
for β-actin. (F) Densitometric analysis of activated caspase-3 in cerebella injected with plasma
exosomes
derived
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3. Discussion
The role of exosomes in radiation response has gained increasing attention in recent
years. Since exosomes can travel to distant sites due to their release in the blood circulation,
they have been suggested as mediators of radiation-induced not-targeted effects [34].
However, this suggestion mostly relies on data derived from purely in vitro experiments
and therefore cannot be directly extrapolated to the in vivo context.
By using an in vivo approach, we have demonstrated here that both the miRNA
and protein cargo of circulating plasma exosomes are significantly affected by radiation
exposure to a dose of 2 Gy, often corresponding to conventional daily fractions during
radiation therapy. Furthermore, exosomes from irradiated mice modulate the level of
apoptosis in the cerebellum of non-irradiated and irradiated neonatal mice by exerting a
robust protective anti-apoptotic effect.
Exosomes are released from cells in every tissue type [43,44], and their secretion is increased by irradiation in a time- and dose-dependent manner [23–25,33,34,45]. Furthermore,
as shown by our data on protein and NGS-based miRNA profiling of plasma exosomes,
both PBI and WBI influence the exosomal cargo and thereby the radiation response in directly irradiated but also in distant, non-irradiated parts of the body. In addition, the cargo
is strongly influenced by the volume of radiation exposed tissue. This is particularly the
case in the miRNA content, while the majority of the deregulated proteins were common
to WBI and PBI exosomes.
Of the five commonly differentially expressed miRNAs in the WBI and PBI groups,
miR-99 shows the highest degree of deregulation. The expression of this miRNA has
already been shown to be radiation responsive [46]. It is involved in the control of DNA
damage response by regulating the expression of SNF2H that in turns influences the level
of BRACA1 [46].
Additionally, miR-182 is among the commonly deregulated miRNAs in WBI and PBI
mice. It is deregulated in the spinal cord of spinal cord injury (SCI) mouse model, and its
overexpression has been shown to improve the functional recovery of the SCI mice through
the suppression of apoptosis and inflammatory response [47]. The neuroprotective effect
of miR-182 in mice following SCI was a consequence of the suppression of apoptosis in
neurons [48]. It was also shown that the inhibition of miR-182-5p increased the sensitivity
to irradiation in nasopharyngeal carcinoma cells, suggesting that miR-182-5p contributes
to cellular radioresistance [49]. Accordingly, miR-182 was upregulated in lung cancer, and
its inhibition sensitized cancer cells to ionizing radiation by suppressing cell proliferation
and increasing cell apoptosis after irradiation, suggesting that miR-182 might account for
radioresistance in lung cancer [50].
Components of the miR-200 family, comprising miR-200a, miR-200b, miR-200c, miR141, and miR-429, are among the most commonly upregulated miRNAs in both WBI and
PBI. MiR-141 and miR-200a are upregulated in the WBI group, while miR-411 and miR-429
are in the PBI groups. Most of the miR-200 studies are in the cancer field, where dysregulation of members of this family has been implied in cell growth and tumor progression in
several tumor types, while its downregulation generally results in decreased cell proliferation [51–54]. Recent studies have also shown that reactive oxygen species (ROS) increase the
expression of miR-200 from endothelial cells [55]. The MiR-200 group has become an important player in the response to anticancer therapies with special regard to the development
of radioresistance [56]. Additionally, all the members of the exosomal miRNAs we found
commonly deregulated in WBI and PBI mice have been shown to produce antiapoptotic
response in many other experimental settings, also involving radiation exposure.
Irradiation also markedly changed the exosomal protein cargo in both PBI and WBI
conditions. Many upregulated proteins were of mitochondrial origin. Mitochondrial
proteins have also been found in the EV cargo previously, mainly in cancer cells but also
in normal somatic cells [57–59]. The function of these proteins in this context is unclear,
but mitochondrial components in EVs isolated from human mesenchymal stem cells were
able to promote aerobic respiration capacity [60] and may therefore help to functionally
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resolve radiation-induced tissue injury [61]. Interestingly, mitochondrial components in the
EV cargo after pro-inflammatory stimulation such as exposure to lipopolysaccharide have
been shown to increase the production of pro-inflammatory cytokines, thereby enhancing
inflammation [59,62,63].
We also found upregulation of Pecam1 and Saa1, the major component of the acute
phase, in the plasma EV cargo of irradiated mice. Both of these proteins have been indicated
in the pro-inflammatory response [48,64]. In contrast, fibrinogens and many ribosomal
proteins were downregulated in the exosomal cargo after irradiation.
A major focus of the present work was to discern whether the radiation-induced
modifications in miRNA and protein cargo in circulating exosomes are (i) detrimental,
propagating radiation damage; or (ii) protective, promoting repair. We have therefore
evaluated the expression of the apoptotic marker caspase-3 after the injection of WBI,
PBI, and SI plasma-derived exosomes in the radiosensitive neonatal mouse cerebellum at
P3 [41,65]. We focused on the brain for two reasons: first, our previous work provided
examples of in vivo out-of-target radiation responses in the brain including induction of
DSBs, apoptosis in the cerebellum [41], and miRNome and proteomic changes following radiation exposure of distant tissues in the hippocampus [66]; second, the brain is
frequently irradiated in patients with central nervous system (CNS) malignancies, and
despite the use of advanced treatment techniques, they often show adverse late outcomes,
including cognitive impairments, especially in pediatric patients [67], and neuroprotective
intervention is strongly needed. The results of the in vivo functional testing, consistent
with the modulation of epigenetic exosomal cargo by irradiation, demonstrated a significant anti-apoptotic role of the WBI- and PBI-derived exosomes in unexposed neonatal
cerebellum. However, functional differences between WBI- and PBI-derived exosomes
were observed with a stronger protective effect of WBI-derived exosomes, as indicated by
the significant anti-apoptotic response in the 2 Gy-irradiated P3 cerebellum that was not
observed with PBI exosomes. Furthermore, exosomes from the WBI group isolated at 1 h
post-irradiation were able to decrease the apoptotic response in neonatal cerebellum, while
PBI-derived exosomes were not. Whether the protective effects of WBI-derived exosomes
in the cerebellum are the direct result of miRNA changes or possibly proteins remains
uncertain. However, given that the majority of the deregulated proteins were in common
between WBI and PBI exosomes, while a higher number of deregulated miRNAs was
detected in the WBI compared to the PBI group, our results support a major functional
role of miRNAs in mediating the exosome-dependent cell-communication response to
radiation exposure.
Significant changes in the miRNAs profile generate subsequent biological effects
through the regulation of their target genes. Our bioinformatics analysis of deregulated
miRNAs in the WBI group, among the targeted pathway, identified the deregulation of signaling by SCF-kit, by PI3K/AKT, angiogenic signaling, and damage-associated molecular
pathways involving DNA damage response/cell cycle regulation and immune responses.
Instead, given the lower number of deregulated miRNAs in the PBI group, pathway analysis only produced indications of interactions with VEGF and VGFR and regulation of
transcription by E2F.
Deregulated pathways in the WBI group strongly affect the regulation of inflammation, which may mediate the systemic response to radiation exposure with a potential
impact on distant organ sites, and modulation of the DNA damage response. Tissue injury
is reported to cause inflammation through the release of damage-associated molecular
patterns (DAMPs) which act upon TLR2, TLR4, and TLR9, thereby inducing TLR signaling
activation [68]. Numerous investigations report protective effects of TLRs against ionizing
radiation. In particular, TLR2, TLR3, TLR4, TLR5, and TLR9 were demonstrated to play
a role in the protection against ionizing radiation [69–73]. Our pathway analysis also
predicted an activation of NF-kB, an important family of transcription factors controlling
inflammatory response, cellular growth, the developmental process, and apoptosis. Many
studies report that NF-kB increased the expression in directly irradiated and bystander
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cells, and the regulation of NF-kB has been shown to be crucial for the bystander response
in non-irradiated cells [74]. Interestingly, the miRNA-dependent deregulated pathways in
circulating exosomes of WBI mice largely overlapped with the pathways perturbed in the
lenses of mice irradiated with 2 Gy -rays 24 h post-irradiation showing a strict interplay
between p53 and TLR signaling [75].
Similarly, irradiated head and neck cancer cells secreted exosomes within 24 h that
increased their survival after irradiation by promoting proliferation and DNA repair efficiency [76]. Similarly, a lower level of apoptosis was observed in irradiated endothelial
cells when pre-incubated with EVs from irradiated donors, suggesting an anti-apoptotic
function [77]. In accordance with our findings, rat plasma-derived exosomes have also been
shown to promote proliferation, migration, and cellular survival in irradiated fibroblasts,
improving the healing of cutaneous post-radiation wound when locally injected [78].
Support for our observations also comes from the field of regenerative medicine, where
numerous studies have been exploring the potential use of mesenchymal stem cells (MSCs)
and MSC exosomes to repair radiation-induced damage in the hematopoietic system, liver,
lung, gastrointestinal tract, and skin [79–81]. Moreover, EVs have been reported to promote
tissue regeneration by creating a pro-regenerative immunomodulatory environment by
steering endogenous cells to repair affected tissues and by switching immune responses
from pro-inflammatory to tolerogenic in animal studies [82].
An increasing number of studies highlight the contribution of exosomes in the CNS,
where, besides being key players in the intercellular communication underlying physiological processes such as synaptic plasticity, they were found to cross the blood–brain barrier
in injured CNS, signaling the propagation of neuroinflammation [83–85] or supporting
neuronal survival under ischemic stress [86–88]. In addition, cranial transplantation of
stem-cell-derived exosomes has been shown to impart significant neuroprotective effects
within the irradiated brain microenvironment [89].
The question of how the contents of the exosomal cargo depends on the nature of donor
and recipient cells remains unsolved. Ex vivo investigations in which exosome preparations
isolated 24 h post-irradiation from WBI or PBI mouse organs or plasma were incubated
with non-irradiated mouse embryonic fibroblasts showed the induction of DNA damage,
and calcium, ROS and nitric oxide signaling [25]. In contrast, we show here that similar
plasma exosome preparations enhance radioresistance when tested in the unexposed or
irradiated mouse cerebellum in vivo. This underlines the difficulties when extrapolating
EV function from in vitro to in vivo models. Although we are unable to reconcile this
discrepancy, our in vivo findings strongly support a role for plasma exosomes isolated
from irradiated mice in ameliorating brain radiation-induced toxicity by preventing the
induction of spontaneous and radiation-induced apoptosis in the cerebellum.
Although our group demonstrated the transmission of DNA DSBs, apoptosis, and the
induction of oncogenic bystander effects in the neonatal cerebellum following irradiation
of the lower third of the mouse body [41,90–92], we here show that plasma exosomes from
irradiated mice attenuate neuroinflammatory response and protect the cerebellar neurons
from radiation-induced cell death. These apparently contradictory results can be reconciled,
bearing in mind that the induction of survival mechanisms, mediated by proteomic and
miRNome-driven changes, may in turn promote carcinogenesis through the induction
of cell-death resistance in cells harboring DNA damage. Of note, these findings also
exclude exosome-mediated systems for the transmission of radiation-induced bystander
damage, instead implying other mechanisms in the transportation of detrimental signals
from the irradiated regions to distant non-irradiated cerebellum. Molecular signals could
be transmitted through gap junctions, and/or mediator transfer mechanisms [90,93,94].
Of note, decreased tissue communication by genetic ablation of one copy of Connexin43
reduced the tumor response to radiation in the bystander cerebellum [90].
In summary, WBI and PBI of mice induce changes in miRNA and proteomic profiles
of plasma-derived exosomes that mediate systemic responses to radiation exposure and
thereby have an impact on distant organ sites. However, while the majority of regulatory
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functions of exosomes have been delineated using in vitro systems, there is a big gap
in understanding how these changes are regulated and translated into their functional
importance in vivo. Further experiments are required for a better understanding of exosome
biology in vivo and functional testing in different organ systems. This will greatly enhance
the future promise for exosomes-based therapeutic applications to eventually reduce
radiation side effects in normal tissues.
4. Material and Methods
4.1. Mouse Irradiation
C57Bl/6J female mice of 8 weeks of age were subjected to WBI or PBI with 2.0 Gy of
X-rays. Irradiation was performed using a Gilardoni CHF 320 G X-ray generator (Gilardoni,
Mandello del Lario Italy) operated at 250 kVp, 1 mA for 0.1 Gy and 15 mA for 2.0 Gy, with
Half-Value Layer = 1.6 mm Cu (additional filtration of 2.0 mm Al and 0.5 mm Cu). PBI
was performed by exposing the lower third of the mouse body, whilst the upper two thirds
were shielded with a lead-shield. Additional groups of mice were SI.
4.2. Isolation of Plasma-Derived Exosomes
One or twenty-four hours after SI, PBI, or WBI, animals were sacrificed, blood was
collected from the submandibular vein, and blood plasma was separated and snap-frozen
for later exosome extraction. All the samples were shipped to Oxford Brookes University
(OBU) for exosome isolations and characterization as described previously [25]. RNA was
extracted with the Total Exosome RNA and Protein Isolation Kit (cat 4478545, Invitrogen)
according to the manufacturer’s instructions.
4.3. MicroRNA Profiling from Plasma-Derived Exosomes
To profile miRNAs, exosomal RNA preparations from three biological replicates,
each consisting of pooled plasma from five mice, were used for each treatment group
(n = 15 mice/group) to identify differences between the groups and to avoid individual
variances between samples. RNA samples were mailed to System Biosciences (SBI) for RNAseq analysis utilizing SBI’s Exosome RNA NGS Service (https://www.systembio.com/
services/exosome-services/exo-ngs, accessed on 18 January 2022). Briefly, Illumina NGS
libraries were prepared and sequenced using an Illumina HiSeq2000 sequence analyzer
(Illumina Inc., San Diego, CA, USA). Data analysis occurred using the Maverix Exosome
RNA-seq Analysis platform (Maverix Biomics Inc., San Mateo, CA). The web-based analysis
service included library sequence quality control metrics, normalization of raw sequence
read, data analysis for relative RNA abundance, and identity and differential expression
analysis. Differentially expressed plasma exosome RNAs were reported as log2 fold change
with significance considered at p < 0.05.
4.4. Pathway Analysis of Plasma-Derived Exosomal miRNA
Statistically significant miRNAs (p < 0.05, log fold-change > 1.5) were used for
gene/miRNA enrichment analysis with Cytoscape plug-in “CluePedia” (version 1.1.7)
and “ClueGo” (version 2.1.7) [95]. The pathway analysis was obtained selecting the genes
with a validated miRTarBase (score 0.6) with an enrichment over the 20 top target genes for
each miRNA of the list. The final enriched list was then selected to identify the affected
pathways into the REACTOME database (https://reactome.org, accessed on 18 January
2022), considering a minimum number of genes into the pathway equal to 4 and 2 for WBI
vs. SI and PBI vs. SI lists, respectively, and with a percentage not less than 5 or 4 for the
two conditions, respectively.
4.5. Mass Spectrometry (MS) Sample Preparation and Measurement for Protein Profiling of
Plasma-Derived Exosomes
The proteomics analysis was performed using three biological samples, each pooled
from plasma EVs isolated from 10 mice in order to reach sufficient amount of material.
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Measures of 10 µg of sample were enzymatically digested using a modified filter-aided
sample preparation (FASP) protocol as described previously [96,97]. Peptides were stored
at –20 ◦ C until MS measurement.
MS measurement was performed in the data-dependent acquisition (DDA) mode. MS
data were acquired on a Q Exactive (QE) high-field (HF) mass spectrometer (Thermo Fisher
Scientific Inc. Waltham, MA, USA) as described [98].
4.6. Data Processing—Protein Identification
Proteome Discoverer 2.4 software (Thermo Fisher Scientific; version 2.4.1.15) was used
for peptide and protein identification via a database search (Sequest HT search engine)
against Swiss-Prot mouse database (Release 2020_02, 17061 sequences), considering full
tryptic specificity, allowing for up to one missed tryptic cleavage site, precursor mass
tolerance 10 ppm, fragment mass tolerance 0.02 Da. Carbamidomethylation of Cys was
set as a static modification. Dynamic modifications included deamidation of Asn and Gln,
oxidation of Met, and a combination of Met loss with acetylation on protein N-terminus.
Percolator was used for validating peptide spectrum matches and peptides, accepting
only the top-scoring hit for each spectrum, and satisfying the cutoff values for FDR <1%,
and posterior error probability <0.01. The final list of proteins complied with the strict
parsimony principle.
4.7. Data Processing—Label-Free Quantification
The quantification of proteins was based on the area value of the abundance values
for unique plus razor peptides. Abundance values were normalized in a retention-timedependent manner to account for sample-loading errors. The protein abundances were
calculated summing up the abundance values for admissible peptides. The final abundance
ratio (fold change) was calculated using median abundance values of three replicate analyses each. The statistical significance of the ratio change was ascertained employing the
T-test approach described in Navarro et al. [99] which is based on the presumption that
we look for expression changes for proteins that are just a few in comparison to the number of total proteins being quantified. The quantification variability of the non-changing
“background” proteins can be used to infer which proteins change their expression in a
statistically significant manner. Proteins were defined as significantly up- or downregulated
if they fulfilled the following filtering criteria: fold change of ≥1.30 (upregulation) or ≤0.77
(downregulation), (ii) q (FDR corrected p) ≤0.05, and (iii) protein identification by at least
two unique peptides.
4.8. Data Availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE [100] partner repository with the dataset identifier PXD026408.
4.9. In Vivo Exosomes Transfer
Exosomes isolated from plasma of animals SI, PBI, and WBI after 2 Gy of X-rays
suspended in PBS were intracranially injected in the brain of P3 unirradiated or 2 Gy-WBI
neonatal mice, through a Hamilton microsyringe, using 4 µL per mice (5 − 12.5 × 107/µL).
Mice were sacrificed at 6 h post-injection or post-irradiation and brain tissue was snapfrozen or collected for histology.
4.10. Histological Analysis
After exosome injection, to assess the injection site, cerebella of C57Bl/6 pups (n = 3)
were processed for histology by standard techniques, and cerebella sections were cut (4 µm)
for H&E staining and microscopic morphological examination.
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4.11. Western Blot
For immunoblot, total proteins were extracted from cerebella (n = 2) at P3. Experimental groups included sham-injected (PBS) mice; mice injected with 0 Gy-plasma-derived
exosomes (Evs SI (0 Gy); mice injected with 2 Gy PBI-plasma-derived exosomes (Evs PBI
(2 Gy); mice injected with 2 Gy WBI-plasma-derived exosomes (Evs WBI (2 Gy); 2 Gy wholebody-irradiated mice (2 Gy WBI). All brain samples were collected at 6 h post-treatment.
Proteins were extracted, normalized, separated, and immunoblotted as described [76].
To evaluate apoptosis, samples were incubated with Cleaved-caspase-3 (Asp 175) rabbit
polyclonal antibody (dilution 1:1000; Cell Signaling Technology, Danvers, MA, USA). Monoclonal antibody against β-actin (dilution 1:10,000, Sigma-Aldrich, St. Louis, MO, USA)
was used as a loading control. Specific proteins were visualized with ChemiDoc system
XRS+ Biorad and quantified using ImageJ software.
4.12. Statistical Analysis
qPCR and Western blot analyses are reported as means ± standard error of the means
(SEM), and a t-test was used for the determination of statistical difference between groups;
p ≤ 0.05 was considered statistically significant. Analyses were performed using GraphPad
Prism 5.0 (GraphPad Software, San Diego, CA, USA).
5. Conclusions
Using neonatal mouse cerebellum, our group demonstrated in vivo the anti-apoptotic
potential of circulating exosomes derived from the plasma of irradiated mice. This response
was mediated by changes in the exosome cargo, affecting both miRNA and protein contents
and modulating damage-associated molecular pathways, immunoresponse, and angiogenesis. Notably, we show here that exosomes are important in the context of radiation-injured
CNS and prove the relevance of exosomal-mediated neuroprotection in vivo. Such knowledge may pave the road for therapeutic applications of exosomes to the treatment of
radiation injury in the CNS, including the resolution of normal tissue toxicities associated with radiotherapy, although further basic research and technical development will
be required.
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